BodyGuard Life Science -Website Under Maintenance!, page-58

Interesting that the previous round of performance shares that were all issued (18 million in total to BOD); only stipulated the need in Milestone 1, for the BOD to 'execute an agreement to design and develop commercial product(s) ultilising the Company's technologies'.

So Jase, your recent enquiry regarding wanting to see and purchase a finished Coty product will no doubt fall on deaf ears:


http://www.asx.com.au/asxpdf/20111026/pdf/4221cvnps8smsr.pdf




And whatever happened to the BOD's promise back in 2014 for the performance milestones that expire at the end of this year? They advised they will be 'required to assess the likelihood of each of those non-market based performance targets being achieved at each reporting period through the vesting period'?!? Did I miss this assessment in the 2016 Annual report?!?:



http://www.asx.com.au/asxpdf/20141027/pdf/42t729w64mjhk3.pdf




Here's a reminder of what the BOD should be updating Shareholders the 'likelihood' of:



http://www.asx.com.au/asxpdf/20141027/pdf/42t729w64mjhk3.pdf




When the BOD was selling the 2014 Performance Rights to Shareholders back in 2014, they went to alot of trouble to outline the 'likeliehood' of their achievement. Since the approval from Shareholders. it seems that we have been once again left in the dark:


http://www.asx.com.au/asxpdf/20141027/pdf/42t729w64mjhk3.pdf